Concepedia

Alexander B. Afeyan

AB

Statistics

Publications

4

Citations

842

H-Index

4

Active since

2019

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Broad Institute

Dana-Farber Brigham Cancer Center

Alexander B. Afeyan is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and personalized neoantigen vaccines.

ORCID

Publications per year

2019–2025

4

Publications

4

Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells

Cornelia Kröger, Alexander B. Afeyan, Jasmin Mraz et al. · Proceedings of the National Academy of Sciences · 2019 · 531 citations · Full text

, , +16

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

David A. Braun, Giorgia Moranzoni, Vipheaviny Chea et al. · Nature · 2025 · 165 citations · Full text

, , +17

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan et al. · Science Immunology · 2023 · 116 citations · Full text

, , +17

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Eryn Blass, Derin B. Keskin, Chloe Ran Tu et al. · Cell · 2025 · 30 citations · Full text

, , +14

1–4 of 4